Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?

Cancer statistics, 2023

(2023) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial

(2023) Roy S. Herbst et al.   JOURNAL OF CLINICAL ONCOLOGY

Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China

(2023) Shujie Zhou et al.   Radiation Oncology

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

(2023) Heather Wakelee et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

(2022) Patrick M. Forde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer—A Review

(2022) Krisztian Süveg et al.   Cancers

A Cast of Shadow on Postoperative Radiotherapy for pIIIA-N2 Non–Small Cell Lung Cancer?

(2022) Stefania Canova et al.   JAMA Oncology

Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer

(2022) Kristine N. Kim et al.   Clinical Lung Cancer

The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis

(2021) Liu Kai et al.   Journal of Cardiothoracic Surgery

Brief report: Four-year survival with durvalumab after chemoradiotherapy in Stage III NSCLC – an update from the PACIFIC trial

(2021) Corinne Faivre-Finn et al.   Journal of Thoracic Oncology

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer

(2021) David Boyce-Fappiano et al.   Clinical Lung Cancer

Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations

(2021) Jennifer S. Chiang et al.   Journal of Thoracic Disease

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)

(2021) Akira Hamada et al.   Clinical Lung Cancer

Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question

(2021) Paul Van Houtte et al.   Translational Lung Cancer Research

Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART

(2021) Krisztian Süveg et al.   Clinical Lung Cancer

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

(2021) Enriqueta Felip et al.   LANCET

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

(2021) Zhouguang Hui et al.   JAMA Oncology

Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)

(2021) Liang Xia et al.   CLINICAL CANCER RESEARCH

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial

(2021) Cecile Le Pechoux et al.   LANCET ONCOLOGY

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC

(2021) Bin Qiu et al.   Nature Communications

Postoperative intensity‐modulated radiation therapy reduces local recurrence and improves overall survival in III‐N2 non‐small‐cell lung cancer: A single‐center, retrospective study

(2020) Wei Wei et al.   Cancer Medicine

Supraclavicular Recurrence in Completely Resected (y)pN2 Non-Small Cell Lung Cancer: Implications for Postoperative Radiotherapy

(2020) Liang Liu et al.   Frontiers in Oncology

Foreword to ‘The current status and future perspectives on the management of stage III NSCLC: a focus on unresectable cancer treatment paradigms’

(2020) Luis Paz-Ares et al.   BRITISH JOURNAL OF CANCER

Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer

(2019) Yeona Cho et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study

(2019) Wan-Qin Zeng et al.   LUNG

Radiotherapy for patients with completely resected pathologic IIIA(N2) non–small-cell lung cancer: a retrospective analysis

(2019) Ying Zhu et al.   Cancer Management and Research

ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection

(2018) Yi-Long Wu et al.   Clinical Lung Cancer

Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis

(2018) Claudio Luchini et al.   VIRCHOWS ARCHIV

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

(2017) Stephen G. Chun et al.   JOURNAL OF CLINICAL ONCOLOGY

Postoperative Radiotherapy for Pathologic N2 Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base

(2015) Cliff G. Robinson et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy

(2015) Andrew B Sharabi et al.   LANCET ONCOLOGY

The physics of proton therapy

(2015) Wayne D Newhauser et al.   PHYSICS IN MEDICINE AND BIOLOGY

Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer

(2013) Damien Urban et al.   Journal of Thoracic Oncology

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis

(2013) Charlotte Billiet et al.   RADIOTHERAPY AND ONCOLOGY

Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy

(2009) L. Moretti et al.   ONCOLOGIST